1. [O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE. (1st July 2017) Authors: Budur, Kumar; West, Tim; Braunstein, Joel B.; Fogelman, Ilana; Bordelon, Yvette M.; Litvan, Irene; Roberson, Erik D.; Hu, Helen; Verghese, Philip B.; Bateman, Randall J.; Florian, Hana; Wang, Deli; Ryman, Davis; Gault, Laura; Goss, Sandra; Mendonca, Nuno; Rendenbach‐Mueller, Beatrice; Kerwin, Dia... Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dietary Protein and Transitions Between Frailty States and to Death in Advanced Age: LiLACS NZ. (16th December 2020) Authors: Teh, Ruth; Kerse, Ngaire; Mendonca, Nuno; Menzies, Oliver; Hill, Tom; Jagger, Carol Journal: Innovation in aging Issue: Volume 4(2020)Supplement 1 Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Difficult catheter access to the occluded vessel during endovascular treatment of acute ischemic stroke is associated with worse clinical outcome. (31st October 2012) Authors: Ribo, Marc; Flores, Alan; Rubiera, Marta; Pagola, Jorge; Mendonca, Nuno; Rodriguez-Luna, David; Piñeiro, Soco; Meler, Pilar; Alvarez-Sabin, Jose; Molina, Carlos A Journal: Journal of neurointerventional surgery Issue: Volume 5(2013)Supplement 1 Page Start: i70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O1‐02‐06: ABBV‐8E12, A HUMANIZED ANTI‐TAU MONOCLONAL ANTIBODY FOR THE TREATMENT OF EARLY ALZHEIMER'S DISEASE: STUDY DESIGN AND BASELINE CHARACTERISTICS FOR A 96‐WEEK, MULTIPLE DOSE, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY. (1st July 2006) Authors: Florian, Hana; Budur, Kumar; Wang, Deli; Robieson, Weining Z.; Soares, Holly; Braunstein, Joel B.; Holtzman, Dave M.; Bateman, Randall J.; Rendenbach-Mueller, Beatrice; Mendonca, Nuno Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O3‐09‐05: PLASMA TAU AND NEUROFILAMENT LIGHT CHAIN AS A PROGNOSTIC BIOMARKER OF DISEASE PROGRESSION IN EARLY ALZHEIMER'S DISEASE. (1st July 2006) Authors: Soares, Holly; Feng, Sheng; Florian, Hana; Gold, Michael; Lon, Hoi-Kei; Mendonca, Nuno; Rendenbach-Mueller, Beatrice; Budur, Kumar Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7(2018)Part 19 Page Start: P1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. Issue 10 (October 2021) Authors: Mercuri, Eugenio; Muntoni, Francesco; Baranello, Giovanni; Masson, Riccardo; Boespflug-Tanguy, Odile; Bruno, Claudio; Corti, Stefania; Daron, Aurore; Deconinck, Nicolas; Servais, Laurent; Straub, Volker; Ouyang, Haojun; Chand, Deepa; Tauscher-Wisniewski, Sitra; Mendonca, Nuno; Lavrov, Arseniy; Se... Journal: Lancet neurology Issue: Volume 20:Issue 10(2021) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies. Issue 3 (27th July 2018) Authors: Lon, Hoi‐Kei; Mendonca, Nuno; Goss, Sandra; Othman, Ahmed A.; Locke, Charles; Jin, Ziyi; Rendenbach‐Mueller, Beatrice Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 3(2019) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial. Issue 3 (March 2021) Authors: Höglinger, Günter U; Litvan, Irene; Mendonca, Nuno; Wang, Deli; Zheng, Hui; Rendenbach-Mueller, Beatrice; Lon, Hoi-Kei; Jin, Ziyi; Fisseha, Nahome; Budur, Kumar; Gold, Michael; Ryman, Davis; Florian, Hana; Ahmed, Anwar; Aiba, Ikuko; Albanese, Alberto; Bertram, Kelly; Bordelon, Yvette; Bower, Jame... Journal: Lancet neurology Issue: Volume 20:Issue 3(2021) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SOCIOECONOMIC INEQUALITIES IN TRANSITIONS BETWEEN FRAILTY STATES IN THE VERY OLD: THE NEWCASTLE 85+ STUDY. (8th November 2019) Authors: Jagger, Carol; Mendonca, Nuno; Kingston, Andrew; Robinson, Louise; Yadegarfar, Mohammad E; Hanson, Helen; Duncan, Rachel Journal: Innovation in aging Issue: Volume 3(2019)Supplement 1 Page Start: S225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗